150 related articles for article (PubMed ID: 17107748)
1. Immunocytology in the assessment of patients with asymptomatic microhaematuria.
Schmitz-Dräger BJ; Beiche B; Tirsar LA; Schmitz-Dräger C; Bismarck E; Ebert T
Eur Urol; 2007 Jun; 51(6):1582-8; discussion 1588. PubMed ID: 17107748
[TBL] [Abstract][Full Text] [Related]
2. Immunocytology in the assessment of patients with painless gross haematuria.
Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
[TBL] [Abstract][Full Text] [Related]
3. [Analyses of the role of immunocytology in the differential diagnosis of patients with asymptomatic microhematuria].
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Beiche B; Bismarck E; Ebert T
Urologe A; 2008 Feb; 47(2):190-4. PubMed ID: 18064433
[TBL] [Abstract][Full Text] [Related]
4. [Role of immunocytology in the evaluation of patients with painless gross hematuria].
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Ebert T; Bismarck E
Urologe A; 2010 Jun; 49(6):741-6. PubMed ID: 20373094
[TBL] [Abstract][Full Text] [Related]
5. [Influence of blood cells in urine samples on results of screening for urothelial carcinoma with NMP22 bladder chek].
Ueda Y; Kawaguchi R; Takiuchi H; Kokura K; Yoshimoto T; Mitsui Y; Suzuki T; Jun Q; Higuchi Y; Maruyama T; Kondoh N; Nozima M; Yamamoto S; Shima H
Hinyokika Kiyo; 2009 Feb; 55(2):71-4. PubMed ID: 19301610
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
[TBL] [Abstract][Full Text] [Related]
7. Immunocytology in the assessment of patients with asymptomatic hematuria.
Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Mellan Z; Bismarck E; Ebert T
World J Urol; 2008 Feb; 26(1):31-7. PubMed ID: 18075743
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
10. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
12. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder.
Melissourgos ND; Kastrinakis NG; Skolarikos A; Pappa M; Vassilakis G; Gorgoulis VG; Salla C
Urology; 2005 Sep; 66(3):536-41. PubMed ID: 16140073
[TBL] [Abstract][Full Text] [Related]
14. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
15. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
[TBL] [Abstract][Full Text] [Related]
16. The significance of cystoscopy for the diagnosis of urothelial tumour.
Hattori R; Ohshima S; Ono Y; Miyake K
Int Urol Nephrol; 1993; 25(2):135-9. PubMed ID: 8365842
[TBL] [Abstract][Full Text] [Related]
17. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
18. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
19. Comparison of seven screening methods in the diagnosis of bladder cancer.
Sun Y; He DL; Ma Q; Wan XY; Zhu GD; Li L; Luo Y; He H; Yang L
Chin Med J (Engl); 2006 Nov; 119(21):1763-71. PubMed ID: 17097029
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of urinary cytology in the diagnosis of urothelial tumors].
Benizri E; Volpe P; Bastéris B; Poisson J; Chevallier D; Peyrottes A; Colomb F; Amiel J; Kermarec J; Toubol J
J Urol (Paris); 1995; 101(2):77-9. PubMed ID: 8522858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
